PRESS RELEASE published on 09/09/2024 at 22:43, 1 year 4 months ago Rapport CAC sur l'information financière semestrielle 2024
BRIEF published on 09/09/2024 at 22:40, 1 year 4 months ago ABIVAX présente ses résultats semestriels 2024 Résultats Semestriels Abivax Cybersécurité Contrôle Interne Défaillances
BRIEF published on 09/09/2024 at 22:40, 1 year 4 months ago ABIVAX presents its 2024 half-year results Cybersecurity Abivax Half-year Results Internal Control Failures
PRESS RELEASE published on 09/09/2024 at 22:35, 1 year 4 months ago Lettre d'affirmation sur les comptes semestriels 2024 Lettre d'Affirmation Comptes Semestriels Consolidés IFRS de ABIVAX S.A. pour la période du 1 janvier 2024 au 30 juin 2024, validée par PwC Audit et Agili(3F) Audit IFRS Comptes Semestriels ABIVAX S.A. PwC Audit Agili(3F) Audit
PRESS RELEASE published on 09/09/2024 at 22:18, 1 year 4 months ago Rapport financier semestriel 2024
BRIEF published on 09/09/2024 at 22:06, 1 year 4 months ago Résultats financiers d'Abivax pour le premier semestre 2024 Résultats Financiers Biotechnologie Abivax Premier Semestre 2024 Mécanismes Immunitaires
BRIEF published on 09/09/2024 at 22:06, 1 year 4 months ago Abivax financial results for the first half of 2024 Financial Results Biotechnology Abivax First Half Of 2024 Immune Mechanisms
PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 4 months ago Abivax presents first-half 2024 financial results Abivax presents first-half 2024 financial results with a cash balance of EUR 222M at June 30, 2024. The company focuses on developing therapies for chronic inflammatory diseases Financial Results Abivax Therapeutics Chronic Inflammatory Diseases EUR 222M
PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 4 months ago Abivax présente ses résultats financiers du premier semestre 2024 Abivax présente ses résultats financiers semestriels 2024 avec une trésorerie de 222 millions d'euros au 30 juin 2024, assurant le financement jusqu'au Q4 2025 Résultats Financiers Abivax Bilan Trésorerie Dépenses
BRIEF published on 08/29/2024 at 18:05, 1 year 5 months ago ABIVAX : État des actions et des droits de vote au 31 juillet 2024 Euronext Paris Droits De Vote Actions Abivax Réglementaire
Published on 02/03/2026 at 23:30, 1 hour 19 minutes ago FutureGen Industries Retains Market-Making Services
Published on 02/03/2026 at 23:12, 1 hour 37 minutes ago Appointment of Credit Advisor for Stage 1 Operations
Published on 02/03/2026 at 22:30, 2 hours 19 minutes ago Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million
Published on 02/03/2026 at 22:25, 2 hours 24 minutes ago VIDAA Selects Amdocs MarketONE to Power a New Generation of OTT Subscription and Streaming Bundles on Smart TVs
Published on 02/03/2026 at 20:57, 3 hours 52 minutes ago EQS-Adhoc: tick Trading Software AG adjusts forecast for the current 2025/2026 fiscal year
Published on 02/03/2026 at 20:36, 4 hours 13 minutes ago Freelance.com: Agenda de communication financière 2026-2027
Published on 02/03/2026 at 20:05, 4 hours 44 minutes ago KHUFU'S IN EGYPT NAMED NO.1 AT MIDDLE EAST & NORTH AFRICA'S 50 BEST RESTAURANTS 2026
Published on 02/03/2026 at 19:50, 4 hours 59 minutes ago Blockchain.com & Ondo Finance Launch Onchain Tokenized U.S. Stocks Across Europe
Published on 02/03/2026 at 18:00, 6 hours 49 minutes ago Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 7 hours 4 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 7 hours 4 minutes ago Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)
